Hepatitis B virus infection in post-vaccination South Africa: occult HBV infection and circulating surface gene variants.

Hepatitis B virus infection in post-vaccination South Africa: occult HBV infection and circulating surface gene variants.
复制标题

DOI:
10.1016/j.jcv.2014.11.032
复制
发表时间:
2015-02
期刊:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
影响因子:
--
通讯作者:
Mphahlele MJ
Mphahlele MJ
中科院分区:
其他
文献类型:
--
作者:
Amponsah-Dacosta E;Lebelo RL;Rakgole JN;Selabe SG;Gededzha MP;Mayaphi SH;Powell EA;Blackard JT;Mphahlele MJ

文献摘要

被引文献

相似文献

本研究的目的是调查南非人群中隐性B型肝炎病毒(HBV)感染的患病率和在普及B型肝炎疫苗接种近20年后传播的HBV表面(S)基因变异。从先前的血清学调查中,确定了201份具有暴露于HBV的血清学证据的血清样本,并将其分层为疫苗引入后和引入前人群。对于所有样本,使用实时PCR检测筛选和定量HBV DNA,并与HBV血清学标志物一起分析结果。如果HIV结果可用,则进行子集分析。对37株HBV S基因进行PCR扩增和序列分析。隐匿性HBV感染的患病率从疫苗引入前的70.4%降至疫苗引入后的66.0%。在疫苗引入后的人群中,HIV感染与隐匿性HBV感染的患病率增加之间存在相关性,尽管这在统计学上并不显著。此外,序列分析显示以下HBV亚型; A1(n = 34),A2(n = 2)和罕见的D4分离株。分离出HBV S基因变异体,包括诊断性逃逸突变体。南非疫苗接种后隐匿性HBV感染的患病率有所下降,尽管在HIV合并感染人群中疾病负担仍然很大。经过近20年的普及B型肝炎疫苗接种计划,没有观察到疫苗逃逸突变体的阳性选择。
The aim of this study was to investigate the prevalence of occult hepatitis B virus (HBV) infection and the HBV surface (S) gene variants circulating in the South African population after nearly two decades of universal hepatitis B vaccination. From a previous serosurvey, 201 serum samples with serological evidence of exposure to HBV were identified and these were stratified into post- and pre-vaccine introduction populations. For all samples, HBV DNA was screened and quantified using a real-time PCR assay and results analysed together with HBV serological markers. Where HIV results were available, subset analysis was performed. The HBV S gene was PCR-amplified and sequences analysed for a total of 37 isolates. The prevalence of occult HBV infection reduced from 70.4% in the pre-vaccine introduction era to 66.0% post-vaccine introduction. There was an association between HIV infection and an increase in prevalence of occult HBV infection within the post-vaccine introduction population, although this was not statistically significant. Furthermore, sequence analysis revealed the following HBV subgenotypes; A1 (n = 34), A2 (n = 2) and a rare D4 isolate. HBV S gene variants, including diagnostic escape mutants were isolated. There was a decline in the prevalence of occult HBV infection in post-vaccination South Africa, although the disease burden remains significant in the HIV co-infected population. After nearly two decades of a universal hepatitis B vaccination programme, no positive selection of vaccine escape mutants were observed.